OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award
FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer
Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2
Bob Li Highlights a Major Step Toward More Equitable Cancer Trials
Busy Philipps Reveals Oligodendroglioma Diagnosis: Symptoms, Treatment and Prognosis
The Invisible Patient: When Caring for Cancer Becomes Its Own Toxicity
10 Must-Read Posts In Radiotherapy This Week: August 24-30
RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […]
The “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at 6:30 PM CEST (8:30 PM AMT). Part of the ESMO Therapeutic Landscapes series, the session will focus on recognising, preventing, and managing toxicities associated with […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom. This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026, organized by the European Society for Medical Oncology (ESMO), will take place on September 30, 2026, at 6:30 PM CEST (8:30 PM AMT). The webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC), […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place […]
The ESMO Congress 2026 will take place from 23–27 October in Madrid, Spain, bringing together oncology professionals from around the world. This global event serves as a key platform for […]
The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona, Spain, from November 11–12, 2026. This specialized educational program is co-chaired by Simon Ekman, Lizza Hendriks, and Natasha Leighl, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies […]
The ESMO Advanced Course on Cholangiocarcinoma 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 13–14, 2026, in Barcelona, Spain. The course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma, covering diagnostic challenges, clinical and molecular differences between disease subtypes, adjuvant and […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the exchange of the latest research, promotes ethical dialogue, and highlights technological innovation in cancer care. It brings together healthcare and digital health experts from around […]
The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 18, 2026, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar. The session will review recent progress and remaining challenges in cervical cancer management, including […]
The ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2− mBC Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on […]
